Table 1 The mean ADA activity (with range) in the CSF of TBM patients (n = 117), non-TBM infectious meningitis patients (n = 60) and control patients with non-infectious neurological disorders (n = 104). The data are expressed as mean ± SD
Patient groups | ADA activity (U/L/min) Mean ± SD | Range |
|---|---|---|
1. Tuberculous Meningitis (n = 117) | 14.31 ± 3.87 | 2.99–26.94 |
Culture positive (n = 27) | 17.67 ± 4.18 | 9.01–26.94 |
Clinically suspected (n = 90) | 13.29 ± 3.16 | 2.99–21.02 |
2. Non TBM infectious meningitis (n = 60) | 9.25 ± 2.14 | 4.99–13.96 |
Pyogenic meningitis (n = 41) | 10.11 ± 1.99 | 5.11–13.96 |
Viral meningitis (n = 19) | 7.39 ± 0.93 | 4.99–9.00 |
3. Non-infectious neurological disorders (n = 104) | 2.71 ± 1.96 | 0.00–7.68 |
Headache (n = 32) | 0.98 ± 0.19 | 0.11–1.20 |
Stroke (n = 29) | 4.18 ± 1.19 | 1.92–5.83 |
Venous sinus thrombosis (n = 13) | 1.82–4.12 | |
Guillian-Barré syndrome (n = 12) | 5.38 ± 2.16 | 2.63–7.68 |
Epilepsy (n = 6) | 2.36 ± 0.79 | 1.01–3.18 |
Other neurological disorders (n = 12) | 1.18 ± 0.47 | 0.5–1.87 |